...
首页> 外文期刊>Renal failure. >Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria
【24h】

Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria

机译:血糖控制对高蛋白尿正常的2型糖尿病患者微量白蛋白尿形成的影响

获取原文
           

摘要

This study was aimed at revealing the factors and the interrelationships between factors on microalbuminuria development among type 2 diabetes (T2D) patients. Between 2004 and 2011, 461 T2D patients with a baseline urine albumin-to-creatinine ratio (UACR) of 60?mL/min were evaluated retrospectively. Sixty-eight (14.8%) subjects had developed microalbuminuria in a mean follow-up of 6.82 years. Statistical analysis had revealed that the higher baseline UACR (10?mg/g; sensitivity, 80.9%, specificity, 63.6%; AUC?=?0.774) and glycohemoglobin level (HbA1c) (8%; sensitivity, 72.1%, specificity, 61.6%; AUC?=?0.698) were the two independent microalbuminuria risk factors. When considering the risk of microalbuminuria, the data were normalized with respect to subjects with low-normal UACR (?8%, high-normal UACR/HbA1c?8% were 2.59 (p?=?0.107), 6.15 (p?=?0.001), and 16.96 (p?10%) showed a progressively increase of the hazard risk in baseline high-normal UACR group. But the same correlation was not shown in the low-normal UACR group. This study identified the relationships of high-normal albuminuria and glycemic control on microalbuminuria development among T2D patients. Glycemic control is especially beneficial for T2D patients with baseline high-normal UACR in preventing microalbuminuria development.
机译:这项研究旨在揭示2型糖尿病(T2D)患者中微量白蛋白尿形成的因素及其因素之间的相互关系。在2004年至2011年期间,对461例T2D患者的基线尿白蛋白/肌酐比值(UACR)为60?mL / min进行了回顾性评估。六十八名(14.8%)受试者平均随访时间为6.82年,发展为微量白蛋白尿。统计分析表明,基线UACR(10?mg / g;敏感性为80.9%,特异性为63.6%;AUCα=?0.774)和糖化血红蛋白水平(HbA1c)较高(8%;敏感性为72.1%,特异性为61.6) (%;AUC≥= 0.698)是两个独立的微量白蛋白尿危险因素。考虑微白蛋白尿的风险时,将UACR较低的受试者的数据标准化(≥8%,UACR / HbA1c≥8%的正常受试者为2.59(p?=?0.107),6.15(p?=?)。 0.001)和16.96(p?10%)表示基线高正常UACR组的危险风险逐渐增加,但低正常UACR组未显示相同的相关性。正常蛋白尿和血糖控制对T2D患者的微量白蛋白尿的发展血糖控制对于基线UACR较高的T2D患者在预防微量白蛋白尿的发展方面尤其有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号